TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $984,350 | -2.3% | 63,630 | -0.8% | 0.03% | -8.8% |
| Q2 2023 | $1,007,947 | -5.2% | 64,160 | -0.5% | 0.03% | -15.0% |
| Q1 2023 | $1,062,970 | +12.3% | 64,501 | +6.3% | 0.04% | -2.4% |
| Q4 2022 | $946,773 | +17.3% | 60,691 | -2.5% | 0.04% | +7.9% |
| Q3 2022 | $807,000 | +9.5% | 62,220 | +18.5% | 0.04% | +15.2% |
| Q2 2022 | $737,000 | – | 52,517 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |